Anixa Biosciences Inc (ANIX) Form 8-K Material Events
Anixa Biosciences Inc (ANIX) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: ANIX
CIK: 715446
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 10/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Haskell & White LLP
Auditor SinceSince 10/31/2017 12:00:00 AM
Lead Engagement PartnerRichard Smetanka
Audit LocationIrvine, California, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 4 | 2026-09-30 | 2026-09-30 | 4 | 0001493152-26-045053 | View SEC Doc Filr Page |
| 4 | 2026-09-28 | 2026-09-24 | 4 | 0001493152-26-044458 | View SEC Doc Filr Page |
| 4 | 2026-09-28 | 2026-09-24 | 4 | 0001493152-26-044457 | View SEC Doc Filr Page |
| 4 | 2026-09-25 | 2026-09-23 | 4 | 0001493152-26-044250 | View SEC Doc Filr Page |
| 4 | 2026-09-14 | 2026-09-10 | 4 | 0001493152-26-042512 | View SEC Doc Filr Page |
| 4 | 2026-09-14 | 2026-09-10 | 4 | 0001493152-26-042502 | View SEC Doc Filr Page |
| 4 | 2026-09-11 | 2026-09-10 | 4 | 0001493152-26-042302 | View SEC Doc Filr Page |
| 10-Q | 2026-09-09 | 2026-07-31 | 10-Q | 0001493152-26-041963 | View SEC Doc Filr Page |
| 4 | 2026-08-03 | 2026-07-31 | 4 | 0001493152-26-035751 | View SEC Doc Filr Page |
| 4 | 2026-07-29 | 2026-07-27 | 4 | 0001493152-26-035122 | View SEC Doc Filr Page |
| 4 | 2026-07-28 | 2026-07-27 | 4 | 0001493152-26-034952 | View SEC Doc Filr Page |
| 4 | 2026-07-27 | 2026-07-27 | 4 | 0001493152-26-034772 | View SEC Doc Filr Page |
| 4 | 2026-07-27 | 2026-07-24 | 4 | 0001493152-26-034723 | View SEC Doc Filr Page |
| 4 | 2026-07-21 | 2026-07-20 | 4 | 0001493152-26-034027 | View SEC Doc Filr Page |
| 4 | 2026-07-20 | 2026-07-20 | 4 | 0001493152-26-033949 | View SEC Doc Filr Page |
| 4 | 2026-07-16 | 2026-07-15 | 4 | 0001493152-26-033461 | View SEC Doc Filr Page |
| 4 | 2026-07-13 | 2026-07-10 | 4 | 0001493152-26-032961 | View SEC Doc Filr Page |
| 4 | 2026-06-17 | 2026-06-16 | 4 | 0001493152-26-029030 | View SEC Doc Filr Page |
| 4 | 2026-06-16 | 2026-06-12 | 4 | 0001493152-26-028827 | View SEC Doc Filr Page |
| 10-Q | 2026-06-10 | 2026-04-30 | 10-Q | 0001493152-26-028105 | View SEC Doc Filr Page |
| 8-K | 2026-03-11 | 2026-03-10 | 8-K | 0001493152-26-009699 | View SEC Doc Filr Page |
| 10-Q | 2026-03-09 | 2026-01-31 | 10-Q | 0001493152-26-009370 | View SEC Doc Filr Page |
| 8-K | 2026-02-09 | 2026-02-09 | 8-K | 0001493152-26-005702 | View SEC Doc Filr Page |
| 4 | 2026-01-29 | 2026-01-28 | 4 | 0001493152-26-004148 | View SEC Doc Filr Page |
| DEF 14A | 2026-01-28 | 2026-01-28 | DEF 14A | 0001493152-26-004035 | View SEC Doc Filr Page |